Arsenic Trioxide with Ascorbic Acid and High-Dose Melphalan: Results of a Phase II Randomized Trial

Arsenic trioxide (ATO) is synergistic with ascorbic acid (AA) and melphalan against myeloma both in vitro and in vivo. The aim of this randomized phase II trial was to determine the safety and efficacy of a combination of ATO, melphalan, and AA as preparative regimen in 48 patients undergoing autolo...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Qazilbash, Muzaffar H., Saliba, Rima M., Nieto, Yago, Parikh, Gaurav, Pelosini, Matteo, Khan, Fatima B., Jones, Roy B., Hosing, Chitra, Mendoza, Floralyn, Weber, Donna M., Wang, Michael, Popat, Uday, Alousi, Amin, Anderlini, Paolo, Champlin, Richard E., Giralt, Sergio
Formato: Artigo
Lenguaje:Inglês
Publicado: 2008
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4112362/
https://ncbi.nlm.nih.gov/pubmed/19041063
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2008.09.019
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares